» Articles » PMID: 6252673

The Direct Measurement of Inhibitory Capacity to Crystal Growth of Calcium Oxalate in Undiluted Urine and in Other Inhibitor Containing Solutions

Overview
Journal Urol Res
Specialty Urology
Date 1980 Jan 1
PMID 6252673
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This paper describes a simple method to measure the capacity of undiluted urine and of other inhibitor containing solutions (PPi and EHDP) to protect a given mass of calcium oxalate crystals from growth. The method has also been used to determine relative urinary saturation with respect to calcium oxalate. It is based on titration with oxalate and measures the critical changes of concentration necessary to reach saturation or to induce crystal growth. From these changes inhibitory capacity as well as the level of urinary saturation can be calculated in terms of differences of concentration products. The use of the methods at present available to measure urinary oxalate are thereby avoided. In order to compare the results from different urines without the need for cumbersome calculations of activity products we have introduced a saturation-inhibition ratio.

Citing Articles

Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.

Senthil D, Subha K, Saravanan N, Varalakshmi P Mol Cell Biochem. 1996; 156(1):31-5.

PMID: 8709973 DOI: 10.1007/BF00239316.


An optical micromethod for the determination of relative crystallisation rates of calcium oxalate in gels: method and preliminary results.

Achilles W, Mergner C, Simon M Urol Res. 1983; 11(2):87-91.

PMID: 6868222 DOI: 10.1007/BF00256952.


Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine.

Hallson P, ROSE G, Sulaiman S Urol Res. 1983; 11(4):151-4.

PMID: 6316611 DOI: 10.1007/BF00256361.


The oxalate-tolerance-value: a whole urine method to discriminate between calcium oxalate-stoneformers and others.

Briellmann T, Hering F, Seiler H, RUTISHAUSER G Urol Res. 1985; 13(6):291-5.

PMID: 4095828 DOI: 10.1007/BF00262659.


Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

Baumann J, Lauber K, Lustenberger F, Wacker M, Zingg E Urol Res. 1985; 13(4):169-74.

PMID: 4049602 DOI: 10.1007/BF00261818.


References
1.
Baumann J, Wacker M . Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques. Urol Res. 1979; 7(3):183-8. DOI: 10.1007/BF00257204. View

2.
Pak C, Hayashi Y, Finlayson B, Chu S . Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J Lab Clin Med. 1977; 89(4):891-901. View

3.
Robertson W, Peacock M, Nordin B . Activity products in stone-forming and non-stone-forming urine. Clin Sci. 1968; 34(3):579-94. View

4.
Meyer J, Smith L . Growth of calcium oxalate crystals. I. A model for urinary stone growth. Invest Urol. 1975; 13(1):31-5. View

5.
Finlayson B, Reid F . The expectation of free and fixed particles in urinary stone disease. Invest Urol. 1978; 15(6):442-8. View